This compound is a complex macrocyclic peptide antibiotic active pharmaceutical ingredient (API) used in pharmaceutical manufacturing. It features multiple amide bonds, amino acid residues, and a lactone ring, contributing to its high molecular weight and polar character.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(2R)-daptomycin
pharmaceutical raw material
9-L-beta-Aspartic acid daptomycin
pharmaceutical raw material
(+/-)-Carisoprodol-d7 (iso-propyl-d7)
pharmaceutical raw material
2-(2,5-Difluorophenyl)pyrrolidine, (R)-
pharmaceutical raw material
Calteridol calcium
pharmaceutical raw material
4-[3-Phenyl-5-(trideuteriomethyl)-1,2-oxazol-4-yl]benzenesulfonamide
pharmaceutical raw material
(3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(5R,8S,11S,14R,15S,21S,24S,27R,30S)-11-[2-(2-aminophenyl)-2-oxoethyl]-21-(3-aminopropyl)-24-(carboxymethyl)-8-[(2R)-1-carboxypropan-2-yl]-5-(hydroxymethyl)-14,27-dimethyl-3,6,9,12,16,19,22,25,28,32,33-undecaoxo-13-oxa-1,4,7,10,17,20,23,26,29-nonazabicyclo[28.2.1]tritriacontan-15-yl]amino]-4-oxobutanoic acid
ORZVJBWXRAJYHN-RWDRXURGSA-N
CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]3[C@H](OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CN4C(=O)C[C@@H](C4=O)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CO)[C@H](C)CC(=O)O)CC(=O)C5=CC=CC=C5N)C
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.